These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 30342550)

  • 41. Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy.
    Crook AM; Turkova A; Musiime V; Bwakura-Dangarembizi M; Bakeera-Kitaka S; Nahirya-Ntege P; Thomason M; Mugyenyi P; Musoke P; Kekitiinwa A; Munderi P; Nathoo K; Prendergast AJ; Walker AS; Gibb DM;
    BMC Med; 2016 Mar; 14():50. PubMed ID: 27004529
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tuberculosis: opportunities and challenges for the 90-90-90 targets in HIV-infected children.
    Rabie H; Frigati L; Hesseling AC; Garcia-Prats AJ
    J Int AIDS Soc; 2015; 18(Suppl 6):20236. PubMed ID: 26639110
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence, incidence, and associated risk factors of tuberculosis in children with HIV living in the UK and Ireland (CHIPS): a cohort study.
    Turkova A; Chappell E; Judd A; Goodall RL; Welch SB; Foster C; Riordan A; Shingadia D; Shackley F; Doerholt K; Gibb DM; Collins IJ;
    Lancet HIV; 2015 Dec; 2(12):e530-9. PubMed ID: 26614967
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HIV-TB co-infection in children: associated factors and access to HIV services in Lagos, Nigeria.
    Daniel OJ; Adejumo OA; Gidado M; Abdur-Razzaq HA; Jaiyesimi EO
    Public Health Action; 2015 Sep; 5(3):165-9. PubMed ID: 26399285
    [TBL] [Abstract][Full Text] [Related]  

  • 45. WHO's new end TB strategy.
    Uplekar M; Weil D; Lonnroth K; Jaramillo E; Lienhardt C; Dias HM; Falzon D; Floyd K; Gargioni G; Getahun H; Gilpin C; Glaziou P; Grzemska M; Mirzayev F; Nakatani H; Raviglione M;
    Lancet; 2015 May; 385(9979):1799-1801. PubMed ID: 25814376
    [No Abstract]   [Full Text] [Related]  

  • 46. Beneficial effect of isoniazid preventive therapy and antiretroviral therapy on the incidence of tuberculosis in people living with HIV in Ethiopia.
    Yirdaw KD; Jerene D; Gashu Z; Edginton ME; Kumar AM; Letamo Y; Feleke B; Teklu AM; Zewdu S; Weiss B; Ruff A
    PLoS One; 2014; 9(8):e104557. PubMed ID: 25105417
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epidemiology and disease burden of tuberculosis in children: a global perspective.
    Seddon JA; Shingadia D
    Infect Drug Resist; 2014; 7():153-65. PubMed ID: 24971023
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Severe manifestations of extrapulmonary tuberculosis in HIV-infected children initiating antiretroviral therapy before 2 years of age.
    Walters E; Duvenhage J; Draper HR; Hesseling AC; Van Wyk SS; Cotton MF; Rabie H
    Arch Dis Child; 2014 Nov; 99(11):998-1003. PubMed ID: 24938535
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial.
    Rangaka MX; Wilkinson RJ; Boulle A; Glynn JR; Fielding K; van Cutsem G; Wilkinson KA; Goliath R; Mathee S; Goemaere E; Maartens G
    Lancet; 2014 Aug; 384(9944):682-90. PubMed ID: 24835842
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tuberculosis in human immunodeficiency virus-infected children starting antiretroviral therapy in Côte d'Ivoire.
    Auld AF; Tuho MZ; Ekra KA; Kouakou J; Shiraishi RW; Adjorlolo-Johnson G; Marlink R; Ellerbrock TV
    Int J Tuberc Lung Dis; 2014 Apr; 18(4):381-7. PubMed ID: 24670690
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of isoniazid prophylactic therapy in prevention of tuberculosis in children: a meta-analysis.
    Ayieko J; Abuogi L; Simchowitz B; Bukusi EA; Smith AH; Reingold A
    BMC Infect Dis; 2014 Feb; 14():91. PubMed ID: 24555539
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incidence and associated factors of pulmonary tuberculosis in HIV-infected children after highly active antiretroviral therapy (HAART) in China: a retrospective study.
    Mu W; Zhao Y; Sun X; Ma Y; Yu L; Liu X; Zhao D; Dou Z; Fang H; Zhang F
    AIDS Care; 2014; 26(9):1127-35. PubMed ID: 24512621
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of antiretroviral therapy on opportunistic infections of HIV-infected children in the therapeutic research, education and AIDS training asia pediatric HIV observational database.
    Prasitsuebsai W; Kariminia A; Puthanakit T; Lumbiganon P; Hansudewechakul R; Siew Moy F; Law M; Kumarasamy N; Razali K; Sirisanthana V; Sohn AH; Chokephaibulkit K
    Pediatr Infect Dis J; 2014 Jul; 33(7):747-52. PubMed ID: 24378942
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incidence of World Health Organization stage 3 and 4 events, tuberculosis and mortality in untreated, HIV-infected children enrolling in care before 1 year of age: an IeDEA (International Epidemiologic Databases To Evaluate AIDS) East Africa regional analysis.
    Ciaranello A; Lu Z; Ayaya S; Losina E; Musick B; Vreeman R; Freedberg KA; Abrams EJ; Dillabaugh L; Doherty K; Ssali J; Yiannoutsos CT; Wools-Kaloustian K
    Pediatr Infect Dis J; 2014 Jun; 33(6):623-9. PubMed ID: 24378935
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predicting the long-term impact of antiretroviral therapy scale-up on population incidence of tuberculosis.
    Dodd PJ; Knight GM; Lawn SD; Corbett EL; White RG
    PLoS One; 2013; 8(9):e75466. PubMed ID: 24069418
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of expanded antiretroviral use on incidence and prevalence of tuberculosis in children with HIV in Kenya.
    Abuogi LL; Mwachari C; Leslie HH; Shade SB; Otieno J; Yienya N; Sanguli L; Amukoye E; Cohen CR
    Int J Tuberc Lung Dis; 2013 Oct; 17(10):1291-7. PubMed ID: 24025380
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Childhood tuberculosis: epidemiology, diagnosis, treatment, and vaccination.
    Tsai KS; Chang HL; Chien ST; Chen KL; Chen KH; Mai MH; Chen KT
    Pediatr Neonatol; 2013 Oct; 54(5):295-302. PubMed ID: 23597517
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incident tuberculosis and risk factors among HIV-infected children in Tanzania.
    Li N; Manji KP; Spiegelman D; Muya A; Mwiru RS; Liu E; Chalamilla G; Fawzi WW; Duggan C
    AIDS; 2013 May; 27(8):1273-81. PubMed ID: 23343909
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Opportunistic and other infections in HIV-infected children in Latin America compared to a similar cohort in the United States.
    Alarcón JO; Freimanis-Hance L; Krauss M; Reyes MF; Cardoso CA; Mussi-Pinhata MM; Cardoso E; Hazra R;
    AIDS Res Hum Retroviruses; 2012 Mar; 28(3):282-8. PubMed ID: 21902581
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The impact of isoniazid preventive therapy and antiretroviral therapy on tuberculosis in children infected with HIV in a high tuberculosis incidence setting.
    Frigati LJ; Kranzer K; Cotton MF; Schaaf HS; Lombard CJ; Zar HJ
    Thorax; 2011 Jun; 66(6):496-501. PubMed ID: 21460373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.